IDR 2430.0
(-1.62%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1997.6 Billion IDR | 64.29% |
2022 | 1670.68 Billion IDR | -29.91% |
2021 | 1434.08 Billion IDR | 3.09% |
2020 | 1393.48 Billion IDR | 31.32% |
2019 | 1082.39 Billion IDR | 11.53% |
2018 | 955.56 Billion IDR | 8.88% |
2017 | 950.75 Billion IDR | -5.49% |
2016 | 907.08 Billion IDR | 1.11% |
2015 | 829.69 Billion IDR | 3.22% |
2014 | 836.95 Billion IDR | -7.72% |
2013 | 911.76 Billion IDR | 5.93% |
2012 | 860.69 Billion IDR | 29.85% |
2011 | 662.81 Billion IDR | 10.96% |
2010 | 597.34 Billion IDR | 35.96% |
2009 | 445.55 Billion IDR | 21.29% |
2008 | 362.24 Billion IDR | 13.94% |
2007 | 320.56 Billion IDR | 1.83% |
2006 | 314.04 Billion IDR | -10.63% |
2005 | 353.48 Billion IDR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 533.2 Billion IDR | 50.44% |
2024 Q3 | 486.69 Billion IDR | -30.22% |
2024 Q2 | 582 Billion IDR | 4.49% |
2023 Q2 | 255.34 Billion IDR | 3.57% |
2023 Q1 | 246.54 Billion IDR | 376.71% |
2023 FY | - IDR | 64.29% |
2023 Q4 | 443.65 Billion IDR | -6.42% |
2023 Q3 | 474.08 Billion IDR | 85.67% |
2022 Q1 | 415.18 Billion IDR | 1.14% |
2022 FY | - IDR | -29.91% |
2022 Q2 | 200.59 Billion IDR | -51.68% |
2022 Q4 | 51.71 Billion IDR | -81.59% |
2022 Q3 | 280.85 Billion IDR | 40.01% |
2021 Q2 | 233.68 Billion IDR | -48.1% |
2021 FY | - IDR | 3.09% |
2021 Q4 | 410.51 Billion IDR | 52.13% |
2021 Q3 | 269.84 Billion IDR | 15.47% |
2021 Q1 | 450.28 Billion IDR | -0.09% |
2020 Q1 | 445.87 Billion IDR | 45.24% |
2020 FY | - IDR | 31.32% |
2020 Q2 | 177.24 Billion IDR | -60.25% |
2020 Q3 | 249.59 Billion IDR | 40.82% |
2020 Q4 | 450.71 Billion IDR | 80.57% |
2019 Q4 | 306.99 Billion IDR | 71.87% |
2019 Q2 | 203.78 Billion IDR | -34.69% |
2019 Q1 | 311.99 Billion IDR | 33.23% |
2019 FY | - IDR | 11.53% |
2019 Q3 | 178.62 Billion IDR | -12.35% |
2018 FY | - IDR | 8.88% |
2018 Q4 | 234.18 Billion IDR | 40.74% |
2018 Q3 | 166.39 Billion IDR | -19.32% |
2018 Q2 | 206.23 Billion IDR | -30.52% |
2018 Q1 | 296.81 Billion IDR | 35.68% |
2017 FY | - IDR | -5.49% |
2017 Q1 | 293.91 Billion IDR | 41.09% |
2017 Q2 | 200.9 Billion IDR | -31.64% |
2017 Q3 | 116.32 Billion IDR | -42.1% |
2017 Q4 | 218.75 Billion IDR | 88.06% |
2016 Q1 | 280.91 Billion IDR | 135.41% |
2016 FY | - IDR | 1.11% |
2016 Q4 | 208.31 Billion IDR | 23.35% |
2016 Q3 | 168.88 Billion IDR | -23.24% |
2016 Q2 | 220.01 Billion IDR | -21.68% |
2015 Q3 | 193.25 Billion IDR | -13.75% |
2015 Q4 | 119.33 Billion IDR | -38.25% |
2015 FY | - IDR | 3.22% |
2015 Q1 | 292.59 Billion IDR | 144.48% |
2015 Q2 | 224.05 Billion IDR | -23.42% |
2014 Q2 | 239.21 Billion IDR | -24.12% |
2014 FY | - IDR | -7.72% |
2014 Q4 | 119.67 Billion IDR | -28.44% |
2014 Q3 | 167.23 Billion IDR | -30.09% |
2014 Q1 | 315.26 Billion IDR | 133.08% |
2013 Q1 | 296.74 Billion IDR | 51.52% |
2013 FY | - IDR | 5.93% |
2013 Q4 | 135.25 Billion IDR | -33.83% |
2013 Q3 | 204.4 Billion IDR | -25.77% |
2013 Q2 | 275.35 Billion IDR | -7.21% |
2012 Q3 | 151.52 Billion IDR | -34.51% |
2012 Q4 | 195.84 Billion IDR | 29.24% |
2012 FY | - IDR | 29.85% |
2012 Q1 | 240.55 Billion IDR | 162.7% |
2012 Q2 | 231.38 Billion IDR | -3.81% |
2011 FY | - IDR | 10.96% |
2011 Q3 | 161.3 Billion IDR | -20.49% |
2011 Q4 | 91.56 Billion IDR | -43.23% |
2011 Q2 | 202.87 Billion IDR | -2.02% |
2011 Q1 | 207.06 Billion IDR | 0.0% |
2010 FY | - IDR | 35.96% |
2009 FY | - IDR | 21.29% |
2008 FY | - IDR | 13.94% |
2007 FY | - IDR | 1.83% |
2006 FY | - IDR | -10.63% |
2005 FY | - IDR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 255.91 Billion IDR | -680.574% |
PT Merck Tbk | 239.49 Billion IDR | -734.099% |
PT Phapros, Tbk | 120.77 Billion IDR | -1554.0% |
PT Pyridam Farma Tbk | 60.69 Billion IDR | -3191.091% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 1323.93 Billion IDR | -50.884% |